Drug therapy of migraine.
Welch
K M
KM
Department of Neurology, Henry Ford Hospital and Health Sciences Center, Detroit, MI 48202.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004879:Ergotamines / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D011985:Receptors, Serotonin / Q000187:drug effects; D018170:Sumatriptan / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D002121:Calcium Channel Blockers; D004879:Ergotamines; D011985:Receptors, Serotonin; D018170:Sumatriptan